Pharma-Bio Industry to Invest $4.3 Billion in Capital/MRO Project Starts in Fourth-Quarter 2013, an Industrial Info News Alert
(firmenpresse) - SUGAR LAND, TX -- (Marketwired) -- 10/07/13 -- Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas) -- Virtually every corner of North America will house a portion of $4.3 billion in capital and maintenance (MRO) projects for the Pharmaceutical-Biotech Industry during the fourth quarter of 2013. A recent survey taken from Industrial Info's forecasts 235 projects with a cumulative total investment value of $4.3 billion that are ready to begin construction before the end of the year.
Other companies featured: (NYSE:JNJ), (NYSE:NVO)
For details, view the entire article by subscribing to Industrial Info's Premium Industry News at , or browse other breaking industrial news stories at .
Industrial Info Resources (IIR), with global headquarters in Sugar Land, Texas, three offices in North America and nine international offices, is the leading provider of global market intelligence specializing in the industrial process, heavy manufacturing and energy markets. Industrial Info's quality-assurance philosophy, the Living Forward Reporting Principle™, provides up-to-the-minute intelligence on what's happening now, while constantly keeping track of future opportunities. To contact an office in your area, visit the "" page.
Contact:
Joe Govreau
713-783-5147
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 07.10.2013 - 04:30 Uhr
Sprache: Deutsch
News-ID 1269981
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
SUGAR LAND, TX
Phone:
Kategorie:
Biotech
Anmerkungen:
Diese Pressemitteilung wurde bisher 156 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Pharma-Bio Industry to Invest $4.3 Billion in Capital/MRO Project Starts in Fourth-Quarter 2013, an Industrial Info News Alert
"
steht unter der journalistisch-redaktionellen Verantwortung von
Industrial Info Resources (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
